Dr Ashraf Azzabi Dr Andrew Hughes Dr Paula Calvert Professor Ruth Plummer Melanie Griffin et al. | Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations | 2005 |
|
Dr Mark Verrill Professor Alan Boddy Julieann Sludden Kevin Fishwick Lynsey Robson et al. | Phase 1 pharmacokinetic (PK) study of CT-2103 given Q2 or Q3 weeks in patients with solid tumors | 2003 |
|
Professor Alan Boddy Dr Mark Verrill Julieann Sludden Kevin Fishwick Lynsey Robson et al. | Pharmacological study of CT-2103 (XyotaxTM), a poly(L-glutamic acid)-paclitaxel conjugate administered every 3 weeks or every 2 weeks in a phase I study | 2002 |
|
Dr Andrew Hughes Dr Paula Calvert Dr Ashraf Azzabi Professor Ruth Plummer Melanie Griffin et al. | Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma | 2002 |
|
Kevin Fishwick
| The EORTC Clinical Research Coordinators Group | 2002 |
|
Dr Andrew Simpson Dr Paula Calvert Julieann Sludden Professor Alan Boddy Melanie Griffin et al. | Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules | 2002 |
|
Dr Andrew Hughes Dr Ashraf Azzabi Professor Ruth Plummer Dr Jane Margetts Kevin Fishwick et al. | A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta (R), multitargeted antifolate). | 2001 |
|
Professor Alan Boddy Melanie Griffin Julieann Sludden Huw Thomas Kevin Fishwick et al. | Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer | 2001 |
|
Professor Alan Boddy Dr Mark Verrill Julieann Sludden Melanie Griffin Kevin Fishwick et al. | Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate | 2001 |
|
Professor Alan Boddy Melanie Griffin Julieann Sludden Huw Thomas Kevin Fishwick et al. | Paclitaxel and carboplatin dose-intensity and duration of infusion in the treatment of ovarian cancer | 2000 |
|
Michael Batey Kevin Fishwick Dr Ashraf Azzabi Professor Herbie Newell Professor Alan Calvert et al. | Population pharmacokinetics of CMF in the adjuvant treatment of breast cancer | 1999 |
|
Kevin Fishwick Lynsey Robson Professor Alan Calvert
| Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancer | 1996 |
|